Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring
CHOICE
Randomized Trial of Diet in Gestational Diabetes Mellitus: Metabolic Consequences to Mother and Offspring
1 other identifier
interventional
105
1 country
1
Brief Summary
The rapidly rising risk of gestational diabetes pregnant women demands that an effective diet strategy be developed due to the high risk of fetal overgrowth, which places the newborn at increased risk for childhood obesity and metabolic syndrome. The aims of this randomized clinical trial are to compare the effects of an 8-wk isocaloric higher complex carbohydrate/lower fat diet vs. a conventional lower carbohydrate (higher fat) diet on glycemic and lipid profiles, maternal insulin resistance, placenta nutrient transporters, the maternal microbiome, neonatal intrahepatic fat, and neonatal total adiposity (primary outcome). The investigators will then follow the infants for 1-yr and measure maternal breast milk and infant microbiome composition to observe if they impact net fat mass gain differently in infants exposed to one diet vs. the other. Identifying a diet for gestational diabetes mellitus women that can effectively alter maternal/fetal metabolism is critical to reducing short- and long-term metabolic risk in this growing cohort of mothers and infants and has the potential to be applicable to overweight/obese pregnant women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2014
CompletedFirst Posted
Study publicly available on registry
September 19, 2014
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2020
CompletedDecember 19, 2020
December 1, 2020
4.3 years
September 15, 2014
December 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neonatal adiposity
Air-displacement plethysmography
5-7 days after birth
Secondary Outcomes (2)
Maternal Insulin Resistance
36 wks gestation
Placental fatty acid transporter protein-2 expression
Delivery
Other Outcomes (3)
Oral glucose tolerance test
Baseline, 36 wks
Adipose Tissue Lipolysis
Baseline, 36 wks
Infant Adiposity
Birth-12 mos
Study Arms (2)
Choosing Healthy Options in Carbohydrate Energy
EXPERIMENTAL60% carbohydrate/25% fat/15% protein diet
Low Carbohydrate/Conventional
ACTIVE COMPARATOR40% carbohydrate/45% fat/15% protein
Interventions
Lower-carbohydrate/conventional diet (usual care)
Choosing Healthy Options in Carbohydrate Energy
Eligibility Criteria
You may qualify if:
- Pregnant women will be between the ages of 20-36 yrs
- BMI of 26-39 kg/m2 at the time of diagnosis
- singleton pregnancy
- no oral hypoglycemic therapy before entering the study
- diagnosed with Gestational diabetes according to the criteria established by the American College of Obstetricians and Gynecologists, specifically, they will have 2 abnormal values on a 100-g 3 hr glucose tolerance test 205, 206: Fasting\>95 mg/dL but \<105 mg/dL; 1hr\> 180 mg/dL; 2 hr\>155 mg/dL; 3 hr\>140 mg/dL.
You may not qualify if:
- extreme hypertriglyceridemia
- overt diabetes
- suspected preexisting diabetes (A1C≥6.5%, Fasting glucose\>125 mg/dL, or random glucose \>200/mg/dL)
- women highly likely to fail diet by any of the following criteria will be excluded:1) Fasting glucose \>105 mg/dL, due to the higher likelihood of failing diet and requiring medical treatment 139; 2) Fasting triglyceride \> 400 mg/dL.
- non-English speaking
- Smokers (leading cause of low birth weight)
- Risk factors for placental insufficiency (hypertension, renal disease, thrombophilias, rheumatologic disease, preeclampsia, steroid use, history of pancreatitis, infectious disease, or intrauterine growth restriction)
- History of pancreatitis
- History of pre-term labor
- Taking beta blockers/glucocorticoids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado/Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Related Publications (1)
Hernandez TL, Van Pelt RE, Anderson MA, Daniels LJ, West NA, Donahoo WT, Friedman JE, Barbour LA. A higher-complex carbohydrate diet in gestational diabetes mellitus achieves glucose targets and lowers postprandial lipids: a randomized crossover study. Diabetes Care. 2014;37(5):1254-62. doi: 10.2337/dc13-2411. Epub 2014 Mar 4.
PMID: 24595632BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teri L Hernandez, PhD, RN
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2014
First Posted
September 19, 2014
Study Start
July 1, 2015
Primary Completion
November 1, 2019
Study Completion
November 1, 2020
Last Updated
December 19, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share